Epilepsy Therapy
Researchers review new antiepileptic drugs for pediatric epilepsy
Published in Medical Letter on the CDC and FDA, April 27th, 2003
According to recent research from the United States, "Epilepsy is one of the most common and challenging neurologic disorders affecting children. Although various modalities exist to treat pediatric-onset seizures, seizures in 25% of children who are diagnosed as having epilepsy remain refractory to available therapies."
"Of the eight new anti-epileptic drugs (AEDs) (felbamate, gabapentin, lamotrigine, topiramate, tiagabine, levetiracetam, oxcarbazepine, and zonisamide), all but two (zonisamide and levetiracetam) have received Food and Drug...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Environmental Toxins
Blood mercury levels low in most women of childbearing age and children - Severe Acute Respiratory Syndrome
Can we halt the deadly SARS? - Bacillus Calmette-Guerin Vaccine
HIV-positive children not particularly vulnerable to BCG M. bovis infection - Biomechanics
Researchers model time-dependent force response of fingertip to dynamic loading - Depression
NIMH launches first public education campaign to reach more than 6 million men - Influenza
New influenza A (H5N1) virus isolated from duck meat - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
